Funding
Turn ideas into impact
Show Me
Due: October 14, 2026
DoW Melanoma Research Program Idea Award
Type
Grant
Source
Federal
Opp Number
HT942526MRPIA
Due: October 14, 2026
Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)
US $500,000
Type
Grant
Source
Federal
Opp Number
PAR-24-252
Due: October 14, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-074
Due: October 14, 2026
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 – Independent Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-23-286
Due: October 14, 2026
DoW Melanoma Research Program Team Science Award
Type
Grant
Source
Federal
Opp Number
HT942526MRPTSA
Due: October 14, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
US $250,000
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-075
Due: October 14, 2026
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 – Independent Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-23-287
Due: October 14, 2026
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 – Independent Basic Experimental Studies with Humans Required)
Type
Grant
Source
Federal
Opp Number
PAR-23-288
Due: October 15, 2026
Advancing Research on Empirically-Supported Interventions for Older Adults Living with Serious Mental Illness (SMI) (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
RFA-MH-27-180
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?